SZOSTAK M ANNE 4
4 · IDEXX LABORATORIES INC /DE · Filed Aug 26, 2025
Insider Transaction Report
Form 4
SZOSTAK M ANNE
Director
Transactions
- Gift
Common Stock
2025-08-22+259→ 259 total(indirect: By Foundation) - Sale
Common Stock
2025-08-22$647.33/sh−2,187$1,415,700→ 262 total - Exercise/Conversion
Common Stock
2025-08-22$206.62/sh+2,187$451,878→ 2,449 total - Gift
Common Stock
2025-08-22−259→ 1,542 total(indirect: By Trust) - Exercise/Conversion
Non-Qualified Stock Option (right-to-buy)
2025-08-22−2,187→ 0 totalExercise: $206.62Exp: 2028-05-07→ Common Stock (2,187 underlying)
Footnotes (5)
- [F1]Represents the weighted average price of the shares sold ranging from a low of $647.30 to a high of $647.45 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- [F2]The reporting person is the settlor of the Trust of M. Anne Szostak ("Trust") and the trustee of the Trust, has power to direct the distribution of Trust assets, and has the power to revoke or amend the Trust. The reporting person has a pecuniary interest in the shares held by the Trust.
- [F3]The reporting person is a trustee of The O'Hanian-Szostak Family Foundation ('Foundation') and has power to direct the distribution of assets held by the Foundation.
- [F4]Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vested in one installment on the one year anniversary of the date of grant or on the date of the 2019 annual meeting of shareholders, whichever event was earlier.
- [F5]Not applicable.